These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 37870420)

  • 1. Role of Albumin as a Targeted Drug Carrier in the Management of Rheumatoid Arthritis: A Comprehensive Review.
    Garg U; Jain N; Kaul S; Nagaich U
    Mol Pharm; 2023 Nov; 20(11):5345-5358. PubMed ID: 37870420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Secreted Protein Acidic and Rich in Cysteine Mediated Biomimetic Delivery of Methotrexate by Albumin-Based Nanomedicines for Rheumatoid Arthritis Therapy.
    Liu L; Hu F; Wang H; Wu X; Eltahan AS; Stanford S; Bottini N; Xiao H; Bottini M; Guo W; Liang XJ
    ACS Nano; 2019 May; 13(5):5036-5048. PubMed ID: 30978282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Uniqueness of Albumin as a Carrier in Nanodrug Delivery.
    Spada A; Emami J; Tuszynski JA; Lavasanifar A
    Mol Pharm; 2021 May; 18(5):1862-1894. PubMed ID: 33787270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secreted protein acidic and rich in cysteine mediates active targeting of human serum albumin in U87MG xenograft mouse models.
    Park CR; Jo JH; Song MG; Park JY; Kim YH; Youn H; Paek SH; Chung JK; Jeong JM; Lee YS; Kang KW
    Theranostics; 2019; 9(24):7447-7457. PubMed ID: 31695779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical impact of serum proteins on drug delivery.
    Kratz F; Elsadek B
    J Control Release; 2012 Jul; 161(2):429-45. PubMed ID: 22155554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Albumin-based drug delivery as novel therapeutic approach for rheumatoid arthritis.
    Wunder A; Müller-Ladner U; Stelzer EH; Funk J; Neumann E; Stehle G; Pap T; Sinn H; Gay S; Fiehn C
    J Immunol; 2003 May; 170(9):4793-801. PubMed ID: 12707361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulating the tumoral SPARC content to enhance albumin-based drug delivery for cancer therapy.
    Zheng B; Chen Y; Niu L; Zhang X; Yang Y; Wang S; Chen W; Cai Z; Huang W; Huang W
    J Control Release; 2024 Feb; 366():596-610. PubMed ID: 38184232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An effective and safe treatment strategy for rheumatoid arthritis based on human serum albumin and Kolliphor
    Gong T; Zhang P; Deng C; Xiao Y; Gong T; Zhang Z
    Nanomedicine (Lond); 2019 Aug; 14(16):2169-2187. PubMed ID: 31397202
    [No Abstract]   [Full Text] [Related]  

  • 9. Recent progress in therapeutic strategies and biomimetic nanomedicines for rheumatoid arthritis treatment.
    Li C; Zheng X; Hu M; Jia M; Jin R; Nie Y
    Expert Opin Drug Deliv; 2022 Aug; 19(8):883-898. PubMed ID: 35760767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomimetic hydroxyapatite as potential polymeric nanocarrier for the treatment of rheumatoid arthritis.
    Ain Q; Zeeshan M; Khan S; Ali H
    J Biomed Mater Res A; 2019 Dec; 107(12):2595-2600. PubMed ID: 31373751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Palmitic acid-modified bovine serum albumin nanoparticles target scavenger receptor-A on activated macrophages to treat rheumatoid arthritis.
    Gong T; Tan T; Zhang P; Li H; Deng C; Huang Y; Gong T; Zhang Z
    Biomaterials; 2020 Nov; 258():120296. PubMed ID: 32781326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prospects for targeting FcR as a novel therapeutic strategy in rheumatoid arthritis.
    Wu Y; Pan W; Hu X; Zhang A; Wei W
    Biochem Pharmacol; 2021 Jan; 183():114360. PubMed ID: 33301760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Folate-conjugated hydrophobicity modified glycol chitosan nanoparticles for targeted delivery of methotrexate in rheumatoid arthritis.
    Wu Z; Xu K; Min J; Chen M; Shen L; Xu J; Jiang Q; Han G; Pan L; Li H
    J Appl Biomater Funct Mater; 2020; 18():2280800020962629. PubMed ID: 33155513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel Nano Carriers for the Treatment of Progressive Auto Immune Disease Rheumatoid Arthritis.
    Mishra R; Gupta S
    Curr Pharm Des; 2021; 27(21):2468-2481. PubMed ID: 33087024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GP60 and SPARC as albumin receptors: key targeted sites for the delivery of antitumor drugs.
    Ji Q; Zhu H; Qin Y; Zhang R; Wang L; Zhang E; Zhou X; Meng R
    Front Pharmacol; 2024; 15():1329636. PubMed ID: 38323081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Albumin nanoscience: homing nanotechnology enabling targeted drug delivery and therapy.
    Lamichhane S; Lee S
    Arch Pharm Res; 2020 Jan; 43(1):118-133. PubMed ID: 31916145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endogenous albumin-mediated delivery of redox-responsive paclitaxel-loaded micelles for targeted cancer therapy.
    Zhang Y; Guo Z; Cao Z; Zhou W; Zhang Y; Chen Q; Lu Y; Chen X; Guo Q; Li C; Liang D; Sun T; Jiang C
    Biomaterials; 2018 Nov; 183():243-257. PubMed ID: 30179775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammation-homing "living drug depot" for efficient arthritis treatment.
    Feng C; Pan L; Qin X; Li D; Chen T; Lin Z; Li G; Wang Q
    Acta Biomater; 2022 Sep; 150():324-336. PubMed ID: 35840107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liposome-Based Nanomedicine Therapeutics for Rheumatoid Arthritis.
    Rahman M; Beg S; Anwar F; Kumar V; Ubale R; Addo RT; Ali R; Akhter S
    Crit Rev Ther Drug Carrier Syst; 2017; 34(4):283-316. PubMed ID: 29199587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methotrexate transport mechanisms: the basis for targeted drug delivery and ß-folate-receptor-specific treatment.
    Fiehn C
    Clin Exp Rheumatol; 2010; 28(5 Suppl 61):S40-5. PubMed ID: 21044432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.